Literature DB >> 31968211

Fecal microbiota transplantation in disease therapy.

Hanna Antushevich1.   

Abstract

Fecal microbiota transplantation (FMT) is the introduction (transplantation) of gut microbiota obtained from the faeces of a healthy donor into the patient's gastrointestinal tract. Most often, such therapy is used the treatment of gastrointestinal diseases caused by the activity of pathogenic or conditionally pathogenic microorganisms, however, recently an increasing number of studies have reported the use of fecal microbiota transplantation for the treatment of diseases such as metabolic syndrome, diabetes, cancer and Parkinson's disease. This review article presents the results of studies concerning the impact of FMT on weight gain, immunological response and the treatment of neurological and gastrointestinal diseases and cancer. The procedure of fecal microbiota transplantation and possible side effects that may appear in FMT recipients are also described.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FMT; Fecal microbiota transplantation; Gastrointestinal diseases; Gut microbiota; Immunological response; Neurological diseases

Year:  2020        PMID: 31968211     DOI: 10.1016/j.cca.2019.12.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  25 in total

1.  Age-specific microbiota in altering host inflammatory and metabolic signaling and metabolome based on sex.

Authors:  Yunchao Wang; Huayu Yang; Haifeng Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

Review 2.  Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.

Authors:  Lili Zhang; Jinjin Chu; Wenhao Hao; Jiaojiao Zhang; Haibo Li; Chunjuan Yang; Jinghan Yang; Xiaohua Chen; Honggang Wang
Journal:  Mediators Inflamm       Date:  2021-08-17       Impact factor: 4.711

Review 3.  Bladder cancer, inflammageing and microbiomes.

Authors:  Austin Martin; Benjamin L Woolbright; Shahid Umar; Molly A Ingersoll; John A Taylor
Journal:  Nat Rev Urol       Date:  2022-07-07       Impact factor: 16.430

Review 4.  Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives.

Authors:  Lie Zheng; Yong-Yi Ji; Xin-Li Wen; Sheng-Lei Duan
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

Review 5.  Implication of Gut Microbiota in Cardiovascular Diseases.

Authors:  Wenyi Zhou; Yiyu Cheng; Ping Zhu; M I Nasser; Xueyan Zhang; Mingyi Zhao
Journal:  Oxid Med Cell Longev       Date:  2020-09-26       Impact factor: 6.543

Review 6.  Bacterial Quorum-Sensing Systems and Their Role in Intestinal Bacteria-Host Crosstalk.

Authors:  Liang Wu; Yubin Luo
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

Review 7.  Gut microbiota: impacts on gastrointestinal cancer immunotherapy.

Authors:  Harry Cheuk Hay Lau; Joseph Jao-Yiu Sung; Jun Yu
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  Loss of QKI in macrophage aggravates inflammatory bowel disease through amplified ROS signaling and microbiota disproportion.

Authors:  Wenwen Wang; Dongsheng Zhai; Yongquan Bai; Ke Xue; Lele Deng; Lirong Ma; Tianshu Du; Zicheng Ye; Di Qu; An Xiang; Guo Chen; Yi Zhao; Li Wang; Zifan Lu
Journal:  Cell Death Discov       Date:  2021-03-23

9.  Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation.

Authors:  Hao-Ming Xu; Hong-Li Huang; Jing Xu; Jie He; Chong Zhao; Yao Peng; Hai-Lan Zhao; Wen-Qi Huang; Chuang-Yu Cao; Yong-Jian Zhou; You-Lian Zhou; Yu-Qiang Nie
Journal:  Front Microbiol       Date:  2021-04-12       Impact factor: 5.640

Review 10.  Understanding autism spectrum disorders with animal models: applications, insights, and perspectives.

Authors:  Zhu Li; Yuan-Xiang Zhu; Li-Jun Gu; Ying Cheng
Journal:  Zool Res       Date:  2021-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.